Resource Library


[Industry Voice #23] NKILT Therapeutics on cell and gene therapy: the next wave of pharma innovation

This episode covers one of the most sought after and critical fields of pharmaceutical research, cell and gene therapy. Our guest, the CEO and сo-founder of NKILT Therapeutics, Raphaël Ognar, describes a cutting-edge cell therapy biotech that is developing a novel approach to directly targeting leukemia.

Thank you for your request!
Our team will respond to you within 24 hours.